Lipospermine-Based Gene Transfer into the Newborn Mouse Brain Is Optimized by a Low Lipospermine/DNA Charge Ratio
Authors:
- Corinne BenoistCBCorinne Benoist
- Bassima AbdallahBABassima Abdallah
- Daniel SchermanDSDaniel Scherman
- Jean-Paul BehrJBJean-Paul Behr
- Barbara A. DemeneixBDBarbara A. Demeneix
- 1 December 1995
- journal article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 6 (12) , 1515-1524
Abstract
Nonviral, plasmid-based gene transfer into somatic tissues offers the prospect of various simple and safe therapeutic possibilities as well as applications in fundamental research. Although cationic lipids display efficient transfection activities in many in vitro systems, only low success rates using these vectors in vivo have been reported. We succeeded in defining conditions providing high levels of in vivo transfection in the brains of newborn mice. Our hypothesis was that conditions favorable for in vitro transfection (highly positively charged particles) were unlikely to be appropriate for in vivo conditions. When using the cationic lipid dioctadecylamido glycylspermine (Transfectam, DOGS) with a cytomegalovirus (CMV)-luciferase reporter gene, the best levels of transfection were obtained when using a low ratio of positive charges (supplied by the DOGS) to negative charges (carried by the DNA). Moreover, addition of the neutral lipid dioleoylphosphatidyl ethanolamine (DOPE) significantly enhanced transfection. Expression of the transgene diminished over time, independently of lipopolysaccharide content of the plasmid preparation used. This suggests that either a mitotic population of cells was preferentially transfected, or that promoter silencing was occurring. Histological examination of the spatial distribution of a beta-galactosidase-expressing transgene showed numerous groups of transfected cells both within the striatal parenchyma and in the paraventricular area. Thus, DNA-lipid complexes bearing overall charges close to neutrality open promising possibilities for modulating gene expression in the developing central nervous system and for therapy in the brain.Keywords
This publication has 29 references indexed in Scilit:
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainNature Genetics, 1994
- Effect of Exogenous Nerve Growth Factor on Neurotoxicity of and Neuronal Gene Delivery by a Herpes Simplex Amplicon Vector in the Rat BrainHuman Gene Therapy, 1994
- Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus, Herpes Simplex Virus, and Retrovirus VectorsHuman Gene Therapy, 1994
- Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal MuscleHuman Gene Therapy, 1993
- Gene Therapy by Intramuscular Injection of Plasmid DNA: Studies on Firefly Luciferase Gene Expression in MiceHuman Gene Therapy, 1993
- Direct Gene Transfer into Skeletal Muscle In Vivo : Factors Affecting Efficiency of Transfer and Stability of ExpressionHuman Gene Therapy, 1993
- Assignment of the beta-thyroid hormone receptor to 3,5,3'- triiodothyronine-dependent inhibition of transcription from the thyrotropin-releasing hormone promoter in chick hypothalamic neuronsMolecular Endocrinology, 1992
- Suppression of audiogenic epileptic seizures by intracerebral injection of a CCK gene vectorNeuroReport, 1992
- A novel cationic liposome reagent for efficient transfection of mammalian cellsBiochemical and Biophysical Research Communications, 1991
- Lipofection of cDNAs in the embryonic vertebrate central nervous systemNeuron, 1990